
The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

